# Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1

> **NCT06435026** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 54 (actual)

## Conditions studied

- HIV
- Prevention
- Pregnancy

## Interventions

- **DRUG:** FTC/TDF 200mg/300mg
- **DRUG:** FTC/TDF 300mg/450mg
- **DRUG:** FTC/TDF 400mg/600mg

## Key facts

- **NCT ID:** NCT06435026
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-18
- **Primary completion:** 2026-02-11
- **Final completion:** 2026-02-11
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06435026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06435026, "Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06435026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*